国际眼科杂志（英文版）（International Journal of Ophthalmology）（国际刊号） 知网目次维普目次

期刊简介

《国际眼科杂志》期刊已被查看： 次

更新频次

高频栏目:

Basic Research-100%-期平均发文量4篇
Clinical Research-100%-期平均发文量13篇
Investigation-83.3%-期平均发文量1篇
Review Article-83.3%-期平均发文量1篇
Letter to the Editor-83.3%-期平均发文量2篇
Intelligent Ophthalmology-83.3%-期平均发文量2篇

中频栏目:

Brief Report-50.0%-期平均发文量1篇
Meta-Analysis-33.3%-期平均发文量1篇
Bibliometric Research-33.3%-期平均发文量1篇

低频栏目:

2024年02期其他-16.7%-期平均发文量2篇
2024年01期其他-16.7%-期平均发文量2篇
2023年12期其他-16.7%-期平均发文量3篇
2023年11期其他-16.7%-期平均发文量2篇
2023年10期其他-16.7%-期平均发文量3篇
Editorial-16.7%-期平均发文量1篇
2023年09期其他-16.7%-期平均发文量3篇

单位占比

一作占比

投稿指南

1、该刊只有国际刊号！

2、投稿方式：在线投稿。

3、刊内网址：http://www.ijo.cn（202404期）

4、投稿系统：https://mc03.manuscriptcentral.com/ijo

5、刊内邮箱：ijopress@163.com

ijo2000@126.com

6、刊内电话：029-82210956；029-82245172

7、出刊日期：月刊，每月18日出版。

2024年4月18日星期四

投稿须知【官网信息】

Instructions for Authors

GENERAL INFORMATION

International Journal of Ophthalmology—IJO, published continuously since 2008, a global ophthalmological scientific publication and a peer-reviewed, open access periodical published in print and online monthly (ISSN: 2222-3959 print, ISSN: 2227-4898 online). IJO is sponsored by the Chinese Medical Association Xi’an Branch, China and obtains guidance, and support from World Health Organization (WHO) and International Council of Ophthalmology (ICO). It is indexed in SCI Expanded, PubMed, PubMed Central, Chemical Abstract, Scopus, EMBASE etc. The latest JCR IF is 1.779. CiteScore in 2020 is 2.5.

Aim & Scope IJO is a comprehensive journal on ophthalmology accepting contributions in English from all over the world. These contributions mainly include original and review articles, both basic and clinical scientific manuscript. With more than 1000 manuscripts received annually, IJO accepts about 26% submitted manuscripts. IJO applies itself to establish a leading ophthalmology journal in the world, to provide a platform for ophthalmologists and impulse the advanced development of ophthalmology.

Manuscript Types  Original Articles (Basic Research and Clinical Research), Review, Meta-Analysis, Commentary, Investigation, Perspective, Opinion, Brief Report, and Letter to the Editor, etc.

Note: Submissions must be an original contribution not previously published (except as an abstract), must not currently be under consideration for publication elsewhere in the similar form, in any language, including both paper and electronic formats.

EDITORIAL POLICIES

Peer Review  All manuscripts are subjected to double blind peer-review and editorial approval before accepting for publication. All contributions will be sent to at least three or more independent reviewers, selected by the editors. Authors are welcome to suggest suitable independent reviewers and may also request that the journal excludes one or two individuals or laboratories, but the editor’s decision on the choice of referees is final. Editors, authors, and reviewers are required to keep confidential all details of the editorial and peer review process on submitted manuscripts, the peer review process is confidential and conducted anonymously; Outcomes of the review process include acceptance, acceptance with revisions but without re-review, revise and resubmit, or rejection. Results of the review process are normally available in about 2-4 months of submission.

Ethical Approval of Studies and Informed Consent  For all manuscripts reporting data from studies involving human participants or animals, a formal review and approval, or formal review and waiver by an appropriate institutional review board or ethics committee is required, and should be described in the Ethical Approval part at the beginning of the Subjects and Methods section. For investigators who do not have a formal ethics review committee (institutional or regional), the principles outlined in the Declaration of Helsinki (as revised in 2013) must be followed. For investigations done in humans, the Methods section must state the manner in which informed consent was obtained from the subjects (i.e., oral, or written), and whether participants received a stipend. If experimental animals were used in the research, IJO requires that authors confirm adherence to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research in the Methods section of their manuscript.

Clinical Trial Registry  When publishing clinical studies, IJO aims to comply with the Recommendations of International Committee of Medical Journal Editors (ICMJE) on trials registration ((http://www.who.int/clinical-trials-registry-platform/the-ictrp-search-portal). Therefore, authors are requested to register the clinical trial presented in the manuscript in a public trial registry, and include the trial registration number in the Methods Section.

Conflicts of Interest A conflict of interest may exist when an author (or the author’s institution or employer) has financial, or personal relationships that could inappropriately influence (or bias) the author’s decisions, work, or manuscript. All authors are required to disclose potential conflicts of interest in the Acknowledgments section of the manuscript by following the Recommendations of the International Committee of Medical Journal Editors (ICMJE) http://www.icmje.org/urm_main.html

……

更多详情：

http://www.ijo.cn/gjyken/ch/first_menu.aspx?parent_id=20120104164955001

上一篇：现代职教研究（内刊）下一篇：互联网与数字经济学（英文）（Journal of Internet and Digital Economics（JIDE））（国际刊号）（不收版面费审稿费）（OA期刊）